Correction: Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling (Journal of Proteome Research (2012) 11:2 (850-860) DOI: 10.1021/pr200685r);Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling

Journal of Proteome Research

Volumn 11, Issue 2, 2012, Pages 850-860

  Brockmöller, Scarlet F ^a   Bucher, Elmar ^b   Müller, Berit M ^a   Budczies, Jan ^a   Hilvo, Mika ^d   Griffin, Julian L ^c   Orešič, Matej ^d   Kallioniemi, Olli ^d   Iljin, Kristiina ^d   Loibl, Sibylle ^f   Darb Esfahani, Silvia ^a   Sinn, Bruno V ^a   Klauschen, Frederick ^a   Prinzler, Judith ^a   Bangemann, Nikola ^a   Ismaeel, Fakher ^a,g   Fiehn, Oliver ^e   Dietel, Manfred ^a   Denkert, Carsten ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f GBG Forschungs GmbH   (Germany)

^g Medizinische Klinik i DRK Kliniken Köpenick   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; GLYCEROPHOSPHATE; HORMONE RECEPTOR; MESSENGER RNA; PHOSPHATIDYLCHOLINE;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER SURVIVAL; CELL METABOLISM; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIPIDOMICS; MASS FRAGMENTOGRAPHY; METABOLOMICS; OVERALL SURVIVAL; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 84856663324     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.2c00181     Document Type: Erratum

References (45)

1. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics Ca-Cancer J. Clin. 2011, 61, 69
2. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics Ca-Cancer J. Clin. 2010, 60 (5) 277-300
3. Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002 Ca-Cancer J. Clin. 2005, 55 (2) 74-108
4. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics Ca-Cancer J. Clin. 2011, 61 (2) 69-90
5. Goldhirsch, A.; Ingle, J. N.; Gelber, R. D.; Coates, A. S.; Thurlimann, B.; Senn, H. J. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 Ann. Oncol. 2009, 20 (8) 1319-29
6. Wood, L. D.; Parsons, D. W.; Jones, S.; Lin, J.; Sjoblom, T.; Leary, R. J.; Shen, D.; Boca, S. M.; Barber, T.; Ptak, J.; Silliman, N.; Szabo, S.; Dezso, Z.; Ustyanksky, V.; Nikolskaya, T.; Nikolsky, Y.; Karchin, R.; Wilson, P. A.; Kaminker, J. S.; Zhang, Z.; Croshaw, R.; Willis, J.; Dawson, D.; Shipitsin, M.; Willson, J. K.; Sukumar, S.; Polyak, K.; Park, B. H.; Pethiyagoda, C. L.; Pant, P. V.; Ballinger, D. G.; Sparks, A. B.; Hartigan, J.; Smith, D. R.; Suh, E.; Papadopoulos, N.; Buckhaults, P.; Markowitz, S. D.; Parmigiani, G.; Kinzler, K. W.; Velculescu, V. E.; Vogelstein, B. The genomic landscapes of human breast and colorectal cancers Science 2007, 318 (5853) 1108-13
7. Hirsch, H. A.; Iliopoulos, D.; Joshi, A.; Zhang, Y.; Jaeger, S. A.; Bulyk, M.; Tsichlis, P. N.; Liu, X. S.; Struhl, K. A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases Cancer Cell 2010, 17 (4) 348-61
8. Oresic, M.; Hanninen, V. A.; Vidal-Puig, A. Lipidomics: a new window to biomedical frontiers Trends Biotechnol. 2008, 26 (12) 647-52
9. Reichenbach, S. E.; Tian, X.; Tao, Q.; Ledford, E. B.; Wu, Z.; Fiehn, O. Informatics for cross-sample analysis with comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry (GCxGC-HRMS) Talanta 2011, 83 (4) 1279-88
10. Kind, T.; Fiehn, O. Advances in structure elucidation of small molecules using mass spectrometry Bioanal Rev. 2010, 2 (1-4) 23-60
11. Fiehn, O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks Comp. Funct. Genomics 2001, 2 (3) 155-68
12. Nygren, H.; Seppanen-Laakso, T.; Castillo, S.; Hyotylainen, T.; Oresic, M. Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues Methods Mol. Biol. 2011, 708, 247-57
13. Denkert, C.; Budczies, J.; Kind, T.; Weichert, W.; Tablack, P.; Sehouli, J.; Niesporek, S.; Konsgen, D.; Dietel, M.; Fiehn, O. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors Cancer Res. 2006, 66 (22) 10795-804
14. Denkert, C.; Budczies, J.; Darb-Esfahani, S.; Gyorffy, B.; Sehouli, J.; Konsgen, D.; Zeillinger, R.; Weichert, W.; Noske, A.; Buckendahl, A. C.; Muller, B. M.; Dietel, M.; Lage, H. A prognostic gene expression index in ovarian cancer-validation across different independent data sets J. Pathol. 2009, 218 (2) 273-80
15. Denkert, C.; Budczies, J.; Weichert, W.; Wohlgemuth, G.; Scholz, M.; Kind, T.; Niesporek, S.; Noske, A.; Buckendahl, A.; Dietel, M.; Fiehn, O. Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover Mol. Cancer 2008, 7, 72
16. Warburg, O. On the origin of cancer cells Science 1956, 123 (3191) 309-14
17. Griffin, J. L.; Shockcor, J. P. Metabolic profiles of cancer cells Nat. Rev. Cancer 2004, 4 (7) 551-61
18. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: the next generation Cell 2011, 144 (5) 646-74
19. Hilvo, M.; Denkert, C.; Lehtinen, L.; Muller, B.; Brockmoller, S.; Seppanen-Laakso, T.; Budczies, J.; Bucher, E.; Yetukuri, L.; Castillo, S.; Berg, E.; Nygren, H.; Sysi-Aho, M.; Griffin, J. L.; Fiehn, O.; Loibl, S.; Richter-Ehrenstein, C.; Radke, C.; Hyotylainen, T.; Kallioniemi, O.; Iljin, K.; Oresic, M. Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression Cancer Res. 2011, 71 (9) 3236-3245
20. Gatenby, R. A.; Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 2004, 4 (11) 891-9
21. Shaw, R. J. Glucose metabolism and cancer Curr. Opin. Cell Biol. 2006, 18 (6) 598-608
22. Vander Heiden, M. G.; Cantley, L. C.; Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 2009, 324 (5930) 1029-33
23. Voeller, D.; Rahman, L.; Zajac-Kaye, M. Elevated levels of thymidylate synthase linked to neoplastic transformation of mammalian cells Cell Cycle 2004, 3 (8) 1005-7
24. Kuhajda, F. P. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology Nutrition 2000, 16 (3) 202-8
25. Menendez, J. A.; Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat. Rev. Cancer 2007, 7 (10) 763-77
26. Medes, G.; Thomas, A.; Weinhouse, S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro Cancer Res. 1953, 13 (1) 27-9
27. Furuta, E.; Pai, S. K.; Zhan, R.; Bandyopadhyay, S.; Watabe, M.; Mo, Y. Y.; Hirota, S.; Hosobe, S.; Tsukada, T.; Miura, K.; Kamada, S.; Saito, K.; Iiizumi, M.; Liu, W.; Ericsson, J.; Watabe, K. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1 Cancer Res. 2008, 68 (4) 1003-11
28. Szutowicz, A.; Kwiatkowski, J.; Angielski, S. Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast Br. J. Cancer 1979, 39 (6) 681-7
29. Kuhajda, F. P.; Jenner, K.; Wood, F. D.; Hennigar, R. A.; Jacobs, L. B.; Dick, J. D.; Pasternack, G. R. Fatty acid synthesis: a potential selective target for antineoplastic therapy Proc. Natl. Acad. Sci. U. S. A. 1994, 91 (14) 6379-83
30. Kuhajda, F. P. Fatty acid synthase and cancer: new application of an old pathway Cancer Res. 2006, 66 (12) 5977-80
31. Milgraum, L. Z.; Witters, L. A.; Pasternack, G. R.; Kuhajda, F. P. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma Clin. Cancer Res. 1997, 3 (11) 2115-20
32. Swinnen, J. V.; Vanderhoydonc, F.; Elgamal, A. A.; Eelen, M.; Vercaeren, I.; Joniau, S.; Van Poppel, H.; Baert, L.; Goossens, K.; Heyns, W.; Verhoeven, G. Selective activation of the fatty acid synthesis pathway in human prostate cancer Int. J. Cancer 2000, 88 (2) 176-9
33. Swinnen, J. V.; Roskams, T.; Joniau, S.; Van Poppel, H.; Oyen, R.; Baert, L.; Heyns, W.; Verhoeven, G. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer Int. J. Cancer 2002, 98 (1) 19-22
34. Wendel, A. A.; Lewin, T. M.; Coleman, R. A. Glycerol-3-phosphate acyltransferases: rate limiting enzymes of triacylglycerol biosynthesis Biochim. Biophys. Acta 2009, 1791 (6) 501-6
35. Gimeno, R. E.; Cao, J. Thematic review series: glycerolipids. Mammalian glycerol-3-phosphate acyltransferases: new genes for an old activity J. Lipid Res. 2008, 49 (10) 2079-88
36. Karlsson, E. A.; Wang, S.; Shi, Q.; Coleman, R. A.; Beck, M. A. Glycerol-3-phosphate acyltransferase 1 is essential for the immune response to infection with coxsackievirus B3 in mice J. Nutr. 2009, 139 (4) 779-83
37. Collison, L. W.; Murphy, E. J.; Jolly, C. A. Glycerol-3-phosphate acyltransferase-1 regulates murine T-lymphocyte proliferation and cytokine production Am. J. Physiol.: Cell Physiol. 2008, 295 (6) C1543-9
38. Hammond, L. E.; Gallagher, P. A.; Wang, S.; Hiller, S.; Kluckman, K. D.; Posey-Marcos, E. L.; Maeda, N.; Coleman, R. A. Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition Mol. Cell. Biol. 2002, 22 (23) 8204-14
39. Hammond, L. E.; Neschen, S.; Romanelli, A. J.; Cline, G. W.; Ilkayeva, O. R.; Shulman, G. I.; Muoio, D. M.; Coleman, R. A. Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs J. Biol. Chem. 2005, 280 (27) 25629-36
40. Elston, C. W.; Ellis, I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 1991, 19 (5) 403-10
41. Kilpinen, S.; Autio, R.; Ojala, K.; Iljin, K.; Bucher, E.; Sara, H.; Pisto, T.; Saarela, M.; Skotheim, R. I.; Bjorkman, M.; Mpindi, J. P.; Haapa-Paananen, S.; Vainio, P.; Edgren, H.; Wolf, M.; Astola, J.; Nees, M.; Hautaniemi, S.; Kallioniemi, O. Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues Genome Biol. 2008, 9 (9) R139
42. Miller, L. D.; Smeds, J.; George, J.; Vega, V. B.; Vergara, L.; Ploner, A.; Pawitan, Y.; Hall, P.; Klaar, S.; Liu, E. T.; Bergh, J. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proc. Natl. Acad. Sci. U. S. A. 2005, 102 (38) 13550-5
43. Remmele, W.; Stegner, H. E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 1987, 8 (3) 138-40
44. Denkert, C. Molecular profiling and predictive signatures. Biomarker analysis in ovarian cancer Pathologe 2008, 29 (Suppl 2) 168-71
45. Sul, H. S.; Wang, D. Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription Annu. Rev. Nutr. 1998, 18, 331-51